Tag: stability storage

Cambrex, a leading global contract development and manufacturing organization (CDMO) providing drug substance, drug product, and analytical services across the entire drug lifecycle, yesterday celebrated the grand opening of its new Q1 Scientific facility in Belgium and announced the signing of a new commercial agreement with QUALIblood, a Belgium-based contract research organization supporting pharmaceutical companies, … Continued

Cambrex, a leading global contract development and manufacturing organization (CDMO) providing drug substance, drug product, and analytical services across the entire drug lifecycle, today announced that their stability storage business, Q1 Scientific, has opened a new 20,000 sq ft cGMP facility in Belgium, expanding its capacity for environmentally-controlled stability storage services to the pharmaceutical, medical … Continued

Pharmaceutical and medical device companies often rely on external suppliers such as Q1 Scientific for the development and production of various components of their products. To ensure the safety and quality of their products, pharmaceutical companies or medical device companies with combination products often require their suppliers to complete establishment registration with the FDA.

Join Dr. Mark Powell on Tuesday 21st March at 2 pm (GMT) for our next free webinar where he discusses managing drug-related degradation products

Q1 Scientific, which offers environmentally controlled stability storage services to the pharmaceutical, medical device and life sciences industries, today announced that Cécile Jacoby has been appointed General Manager at the new Q1 Scientific Belgium facility. With more than 25 years of experience in senior strategic and operations roles across pharmaceutical, vaccine, healthcare and cell therapy … Continued

Cambrex today announced the expansion of their stability storage business, Q1 Scientific, which offers environmentally-controlled stability storage services to the pharmaceutical, medical device and life sciences industries.  Q1 Scientific will open a new 20,000 sq ft cGMP facility in Belgium and add an additional 10,000 sq ft at their existing facility in Waterford, Ireland.  The … Continued

Are you joining us at stability studies 2022? This year, we are looking forward to our first ever Stability Studies conference with a full line-up of pharmaceutical industry experts. Joining us at the conference as a guest speaker is Ken O’Shea, Founder and Managing Director of Qbd Pharma Solutions and Co-founder and CTO of new … Continued

The rapidly accelerating demand for combination products continues to drive technological advances in merging product types. However, the convergence of pharmaceuticals with medical devices brings a host of new challenges in stability studies and storage. At a high level the FDA defines combination products as “therapeutic and diagnostic products that combine drugs, devices, and/or biological … Continued

In any standard refrigerated chamber, the average humidity will read between 90 – 100% relative humidity (RH). When RH can rise to 90 – 100% in a cold chamber, the formation of condensation is pretty much inevitable so how can you take control of cold chamber humidity?

Pharmaceutical manufacturers must establish the stability of their drug products towards light.  But what makes a drug molecule or formulation unstable to light, and how can appropriate protection be given? Find out in this guest post from Dr. Mark Powell on photostability testing.